Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

VPH

Valeo Pharma (VPH)

Valeo Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:VPH
DateHeureSourceTitreSymboleSociété
25/04/202423h55PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERSTSX:VPHValeo Pharma Inc
09/04/202413h00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
22/03/202412h00PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
14/03/202422h29PR Newswire (Canada)VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTSTSX:VPHValeo Pharma Inc
07/03/202413h00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
13/02/202413h00PR Newswire (Canada)VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGESTSX:VPHValeo Pharma Inc
02/02/202423h03PR Newswire (Canada)VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LPTSX:VPHValeo Pharma Inc
29/01/202423h48PR Newswire (Canada)VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023TSX:VPHValeo Pharma Inc
22/01/202413h00PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
20/11/202313h00PR Newswire (Canada)VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVESTSX:VPHValeo Pharma Inc
07/11/202313h15PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
04/10/202313h00PR Newswire (Canada)VALEO PHARMA MAKES THE LIST OF THE GLOBE AND MAIL'S FIFTH-ANNUAL RANKING OF CANADA'S TOP GROWING COMPANIESTSX:VPHValeo Pharma Inc
27/09/202313h00PR Newswire (Canada)VALEO PHARMA ENTERS INTO $5 MILLION CREDIT FACILITY AGREEMENT WITH ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
27/09/202313h00PR Newswire (Canada)VALEO PHARMA CONCLUT UNE ENTENTE DE FACILITÉ DE CRÉDIT DE 5 MILLIONS $ AVEC ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
14/09/202302h01PR Newswire (Canada)VALEO PHARMA ANNONCE DES REVENUS RECORDS POUR LE TROISIÈME TRIMESTRE DE 2023TSX:VPHValeo Pharma Inc
14/09/202301h44PR Newswire (Canada)VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUESTSX:VPHValeo Pharma Inc
07/09/202313h00PR Newswire (Canada)VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
01/09/202301h11PR Newswire (Canada)Investissement Québec conclut un placement privé dans Valeo Pharma Inc.TSX:VPHValeo Pharma Inc
01/09/202300h27PR Newswire (Canada)VALEO PHARMA CONCLUT UN FINANCEMENT DE 4,5 MILLIONS $TSX:VPHValeo Pharma Inc
01/09/202300h10PR Newswire (Canada)VALEO PHARMA CLOSES $4.5 MILLION FINANCINGTSX:VPHValeo Pharma Inc
22/06/202313h00PR Newswire (Canada)VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTSTSX:VPHValeo Pharma Inc
07/06/202313h00PR Newswire (Canada)VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
25/05/202313h00PR Newswire (Canada)VALEO PHARMA PROVIDING GUIDANCE OF RECORD REVENUES FOR THE SECOND QUARTER 2023TSX:VPHValeo Pharma Inc
28/04/202313h43PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS AND COMMITTEE APPOINTMENTSTSX:VPHValeo Pharma Inc
19/04/202313h00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2023 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
15/03/202322h00PR Newswire (Canada)VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023TSX:VPHValeo Pharma Inc
09/03/202313h00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
07/02/202313h00PR Newswire (Canada)VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBECTSX:VPHValeo Pharma Inc
26/01/202313h00PR Newswire (Canada)VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION-COVID 19 WITH HEALTH CANADA FOR SABIZABULIN FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTSTSX:VPHValeo Pharma Inc
25/01/202315h38PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
 Showing the most relevant articles for your search:TSX:VPH